Publikasi

Web App Helps Flag Antibodies Where Manufacturability M...

A web app for analyzing antibody structure could help drug manufacturers assess ...

Bioproduction Pivots from Centralized to Regional Support

The global biopharma industry is placing increasing importance on regional suppo...

Gentler Cell Separation Methods Gain Momentum

As cell therapy developers push toward commercial-scale manufacturing, bioproces...

New Antibiotic, Manikomycin, Acts on Novel Ribosomal Ta...

Researchers discovered manikomycin, a novel antibiotic that kills drug-resistant...

Cellares and TScan Agree to Evaluate Automated Manufact...

As TSC-101 is advanced toward a pivotal trial, which is expected to begin later ...

Small Molecules to Big Partnership: Incyte, Genesis Exp...

Behind the expansion of their collaboration, Incyte and Genesis say, is the prom...

Human Hookworm Engineered to Produce, Secrete Anti-Tetr...

Researchers engineered a human hookworm to produce an anti-tetrodotoxin antibody...

The GOAT Of Athletics?

This week in the world of sports science, the GOAT of running, the Single Leg CM...

Facility of the Month: New $326 Million Tower at Connec...

The 190,000-square-foot Connecticut Children's tower project marks the largest e...

GDC fitness to practise concerns rise 26% as regulator ...

The General Dental Council (GDC) received 1,766 new fitness to practise concerns...

Heroin Adulterated with Diabetes Medication Triggers Li...

Medical researchers have identified a dangerous and deceptive trend in the illic...

Leaping Off the Page: The Continuing Evolution of Endoc...

A Q&A with Executive Editor Mark A. Newman about the exciting next step for the ...

GDC move to save £3.2 million

The General Dental Council (GDC) expects to save £3.2 million over five years by...

Why Passive Studying Is the #1 Reason Medical Students ...

If you’re a medical student who feels like you’re studying all the time but your...

Spatial Single‑Cell Platform Reveals Barriers to Antibo...

A new single‑cell spatial pharmacobiology platform visualizes how therapeutic an...

Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Coll...

Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing...